Results 101 to 110 of about 2,726 (200)

A case of Gitelman syndrome with severe hyponatraemia and hypophosphataemia

open access: yes, 2013
Gitelman syndrome (GS) is a renal tubular disorder of the thiazide-sensitive sodium chloride cotransporter, which is located in the distal tubule of the loop of Henle. We present a rare case of GS complicated by severe hyponatraemia and hypophosphataemia.
Yaqub, Sonia   +3 more
core  

Myocardial damage due to hypokalaemia and hypophosphataemia.

open access: yes, 1984
A case of severe hypokalaemia with stupor, skeletal muscle and heart muscle damage is reported. An initial infusion of glucose-insulin and potassium (GIK) produced a temporary clinical improvement with reduction of creatine kinase (CKMB) and elevation of
C. Scoppetta   +5 more
core   +1 more source

Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients

open access: yes, 2015
Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality.
Thormar, Katrin   +3 more
core  

Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

open access: yes, 2016
Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional.
Broman, Marcus   +2 more
core   +2 more sources

Tumor-induced phosphopenic osteomalacia: modern approaches to diagnostics and treatment

open access: yesСовременная ревматология
Phosphopenic osteomalacia (PPOM) is a rare variant of paraneoplastic syndrome caused by tumor synthesis of fibroblast growth factor 23 (FGF23). FGF23 secretion leads to a decrease in phosphate reabsorption and calcitriol levels, which leads to the ...
A. A. Kondrashov   +4 more
doaj   +1 more source

Ferric carboxymaltose-induced hypophosphataemia after kidney transplantation

open access: yes, 2017
Background: Ferric carboxymaltose (FCM) can induce hypophosphataemia in the general population and patients with chronic kidney disease (CKD). Less is known about the effect of FCM in the kidney transplant population.
Hesselink, D. A.   +13 more
core  

Pharmacological management of X‐linked hypophosphataemia

open access: yes, 2018
The most common heritable disorder of renal phosphate wasting, X‐linked hypophosphataemia (XLH), was discovered to be caused by inactivating mutations in the phosphate regulating gene with homology to endopeptidases on the X‐chromosome (PHEX) gene in ...
Imel, Erik A.   +3 more
core   +1 more source

Severe hypercalcaemia and hypophosphataemia with an optimised preterm parenteral nutrition formulation in two epochs of differing phosphate supplementation

open access: yes, 2017
Objective: To compare in two epochs of differing phosphate provision serum calcium, phosphate, potassium, and sodium concentrations and the frequency of abnormality of these electrolytes and of sepsis in preterm infants who received an optimised higher ...
Howe, Rosalind   +15 more
core   +1 more source

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia [PDF]

open access: yes, 2019
X-linked hypophosphataemia (XLH) is the most common cause of inherited phosphate wasting and is associated with severe complications such as rickets, lower limb deformities, pain, poor mineralization of the teeth and disproportionate short stature in ...
Schnabel, D   +19 more
core  

Home - About - Disclaimer - Privacy